GalNAc Conjugation Reagents Market
完整報告名稱與涵蓋範圍
GalNAc Conjugation Reagents Market Size, Share & Trends Analysis Report, By Reagent Type (GalNAc Phosphoramidites and Building Blocks, GalNAc-Loaded Solid Supports, Trivalent and Multivalent GalNAc Ligands and Linkers, Post-Synthesis Conjugation Reagents), By Grade (Research Grade, GMP Grade), By Application (siRNA Therapeutics, Antisense Oligonucleotide Therapeutics, Research and Preclinical Programs), By End User, By Region, and Segment Forecasts, 2026-2035
報告摘要
The GalNAc conjugation reagents market covers N-acetylgalactosamine phosphoramidites and building blocks, GalNAc-loaded solid supports, multivalent ligand-linker constructs and post-synthesis conjugation reagents used to attach hepatocyte-targeting ligands to siRNA and antisense oligonucleotides, in research and GMP grades. Conjugated therapeutic products and general amidites are excluded.
The success of GalNAc-conjugated siRNA and antisense drugs, which achieve durable knockdown of liver targets with quarterly or semi-annual subcutaneous dosing, has made the ligand a standard component of liver-directed oligonucleotide programs across cardiometabolic, hepatic and infectious disease indications. Reagent demand scales with the number of programs and with commercial volumes of approved conjugates, and manufacturers require GMP-grade building blocks with validated impurity profiles and multi-kilogram supply. Suppliers compete on ligand geometry and linker chemistry compatibility with automated synthesis, on freedom to operate around originator patents and on integrated offerings that combine reagents with conjugation services, while generic and biosimilar-style entrants prepare for eventual exclusivity expiries.
North America and Europe host most developers and premium reagent suppliers, with China and South Korea supplying an increasing share of building blocks. Competition involves oligonucleotide reagent specialists, oligonucleotide CDMOs and fine chemical manufacturers.
The InsightAce study includes revenue forecasts in US$ for all reagent type, grade, application and end user and regional segments across 2026-2035, segment-level trend analysis, competitive positioning assessment and company profiles.
授權報價
| Single User | $4,500 USD |
| Enterprise / Global Site Licence | $9,500 USD |
目錄 Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global GalNAc Conjugation Reagents Market Snapshot
Chapter 4. Global GalNAc Conjugation Reagents Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Market Drivers
4.3. Market Challenges
4.4. Emerging Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis - Porter's Five Forces Analysis
4.7. Competitive Landscape and Market Positioning
4.8. Market Opportunity Analysis
Chapter 5. Market Segmentation 1: By Reagent Type Estimates & Trend Analysis
5.1. Reagent Type & Market Share, 2026 & 2035
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analysis, 2026 to 2035, by Reagent Type:
5.2.1. GalNAc Phosphoramidites and Building Blocks
5.2.2. GalNAc-Loaded Solid Supports
5.2.3. Trivalent and Multivalent GalNAc Ligands and Linkers
5.2.4. Post-Synthesis Conjugation Reagents
Chapter 6. Market Segmentation 2: By Grade Estimates & Trend Analysis
6.1. Grade & Market Share, 2026 & 2035
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analysis, 2026 to 2035, by Grade:
6.2.1. Research Grade
6.2.2. GMP Grade
Chapter 7. Market Segmentation 3: By Application Estimates & Trend Analysis
7.1. Application & Market Share, 2026 & 2035
7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analysis, 2026 to 2035, by Application:
7.2.1. siRNA Therapeutics
7.2.2. Antisense Oligonucleotide Therapeutics
7.2.3. Research and Preclinical Programs
Chapter 8. Market Segmentation 4: By End User Estimates & Trend Analysis
8.1. End User & Market Share, 2026 & 2035
8.2. Market Size (Value US$ Mn) & Forecasts and Trend Analysis, 2026 to 2035, by End User:
8.2.1. Oligonucleotide Therapeutics Developers
8.2.2. Oligonucleotide CDMOs
8.2.3. Academic and Research Institutes
Chapter 9. GalNAc Conjugation Reagents Market: Regional Estimates & Trend Analysis
9.1. North America
9.1.1. United States
9.1.2. Canada
9.2. Europe
9.2.1. Germany
9.2.2. United Kingdom
9.2.3. France
9.2.4. Italy
9.2.5. Spain
9.2.6. Rest of Europe
9.3. Asia Pacific
9.3.1. China
9.3.2. Japan
9.3.3. India
9.3.4. South Korea
9.3.5. Australia
9.3.6. Southeast Asia
9.3.7. Rest of Asia Pacific
9.4. Latin America
9.4.1. Brazil
9.4.2. Mexico
9.4.3. Rest of Latin America
9.5. Middle East & Africa
9.5.1. GCC Countries
9.5.2. South Africa
9.5.3. Rest of Middle East & Africa
Chapter 10. Competitive Landscape
10.1. Company Market Positioning Analysis
10.2. Strategic Developments (Partnerships, Expansions, Product Launches, M&A)
Chapter 11. Company Profiles
11.1. Glen Research (Maravai LifeSciences)
11.2. ChemGenes Corporation
11.3. Hongene Biotech Corporation
11.4. LGC Axolabs
11.5. Nitto Denko Avecia Inc.
11.6. ST Pharm Co., Ltd.
11.7. LGC Biosearch Technologies
11.8. Merck KGaA (MilliporeSigma)
11.9. Bachem Holding AG
11.10. BOC Sciences
11.11. Suzhou Synthesis Chemical Co., Ltd.
11.12. Agilent Technologies, Inc. (Nucleic Acid Solutions Division)
11.13. WuXi AppTec (WuXi TIDES)
11.14. Alnylam Pharmaceuticals, Inc. (Technology Licensing)
11.15. Ionis Pharmaceuticals, Inc. (Technology Licensing)
圖表清單 List of Tables & Figures
Table 1. Global GalNAc Conjugation Reagents Revenue Forecast by Reagent Type, 2026-2035 (US$ Mn)
Figure 1. Global GalNAc Conjugation Reagents Market Snapshot, 2026 & 2035
Table 2. Global GalNAc Conjugation Reagents Revenue Forecast by Grade, 2026-2035 (US$ Mn)
Figure 2. Global GalNAc Conjugation Reagents Market Share by Grade, 2026 & 2035
Table 3. Global GalNAc Conjugation Reagents Revenue Forecast by Application, 2026-2035 (US$ Mn)
Figure 3. GalNAc Conjugate Pipeline and Commercial Products Driving Reagent Demand, 2026-2035
Table 4. Global GalNAc Conjugation Reagents Revenue Forecast by End User, 2026-2035 (US$ Mn)
Figure 4. Ligand and Linker Chemistry Options Compatible with Automated Synthesis
Table 5. North America GalNAc Conjugation Reagents Revenue by Country, 2026-2035 (US$ Mn)
Figure 5. Asia Pacific GalNAc Conjugation Reagents Growth Opportunity Analysis
Table 6. Europe GalNAc Conjugation Reagents Revenue by Country, 2026-2035 (US$ Mn)
Figure 6. GMP GalNAc Building Block Supply Chain and Intellectual Property Landscape
Table 7. Asia Pacific GalNAc Conjugation Reagents Revenue by Country, 2026-2035 (US$ Mn)
Figure 7. Competitive Positioning of Key GalNAc Conjugation Reagents Market Participants
Table 8. Latin America and Middle East & Africa GalNAc Conjugation Reagents Revenue Forecast, 2026-2035 (US$ Mn)
提及公司
常見問題
這份報告可以先索取樣本嗎？
可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。
報告價格如何計算？
報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。
下單後多久交付？如何付款？
一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。
量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們